Cleveland Clinic Rheumatology
D

Cytokine Storm: Where Rheumatologists, Oncologists, and ID Meet

By Cleveland Clinic Rheumatology FEATURING David Fajgenbaum
By Cleveland Clinic Rheumatology FEATURING David Fajgenbaum
179 views
April 18, 2023
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
15:26
Cleveland Clinic Rheumatology and Immunology Series

The Facts About COVID-19 Delta Breakthrough Infection and Vaccine Bo…

Feat. L. Calabrese
01:58
Covid-19 Global Rheumatology Alliance

The COVID-19 Global Rheumatology Alliance: Collecting Evidence-Based…

Feat. P. Robinson, J. Yazdany
14:51
ACR Convergence 2021 Coverage

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

Feat. S. Sattui Cortes
08:33
The Journal of Rheumatology

HCQ in Patients With Rheumatic Disease Complicated by COVID-19: Clar…

Feat. S. J. Balevic
15:27
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving…

Feat. L. Wise
07:43
Cleveland Clinic Rheumatology and Immunology Series

Cleveland Clinic ACR 2020 Updates on COVID-19: Has Tocilizumab Prove…

Feat. L. Calabrese
18:35
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID…

Feat. L. Wise
29:06
Cleveland Clinic Rheumatology

Vaccines for IMIDS: State of the Art

Feat. C. Calabrese
51:16
Yale School of Medicine

COVID-19 and Rheumatic Diseases

Feat. V. Chowdhary
24:32
RheumNow

Autoinflammatory: PAH in AOSD, VEXAS, JAKi in Still's, Role of …

Feat. J. Cush, R. Tate, Y. Yusof, B. Mehta, O. Petryna
19:39
Cleveland Clinic Rheumatology

Principles of Managing COVID-19 in High Risk Outpatients

Feat. C. Calabrese
22:24
Cleveland Clinic Rheumatology

JAK Inhibitors in the COVID-19 Era: Assessing the Risks and Benefit

Feat. K. Winthrop
05:35
The Journal of Rheumatology

Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection…

Feat. J. Curtis
22:39
The Journal of Rheumatology

The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

Feat. E. Silverman, J. Rosenbaum, J. Reveille, K. Winthrop
20:38
Cleveland Clinic Rheumatology

COVID-19 and the Risks From Immunomodulatory Therapies

Feat. Z. Wallace
10:00
RheumNow

RheumNow Updates on Pemphigus Vulgaris, the Efficacy of JAK Inhibito…

Feat. J. Cush
05:29
RheumNow

Rheumatic Disease Patients with COVID-19: Is Timing Important for Bi…

Feat. J. Cush
26:25
Cleveland Clinic Rheumatology

Hyperinflammation and Immunomodulatory Drugs Trials in COVID-19

Feat. P. Mehta
14:08
Cleveland Clinic Rheumatology

Managing COVID-19 in Immune-Mediated Inflammatory Disease Patients: …

Feat. C. Calabrese, L. Calabrese, P. Mehta
26:24
Hospital for Special Surgery

COVID-19 in Rheumatology Patients: What Are the Risks and Side Effec…

Feat. S. Sattui Cortes, R. Mackenzie